INFARMED changes prices with new homogeneous groups

INFARMED changes prices with new homogeneous groups

INFARMED has updated the list of Homogeneous Groups and the unit reference prices for the 3rd quarter of 2024 under the Reference Price System. The new list defines the values that will be in force on the market during this period. INFARMED guarantees the accessibility and cost control of medicines with these updates. Read more here

If you need more information on regulatory issues, ELS can certainly help.

Please do not hesitate to contact your local ELS consultant or via email info@elssolutions.pt

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.